These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17726076)

  • 21. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.
    Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P
    Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters.
    Dias JP; Shardell MD; Carlson OD; Melvin D; Caturegli G; Ferrucci L; Chia CW; Egan JM; Basaria S
    Andrology; 2017 Jan; 5(1):31-40. PubMed ID: 27792869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex steroids, precursors, and metabolite deficiencies in men with isolated hypogonadotropic hypogonadism and panhypopituitarism: a GCMS-based comparative study.
    Giton F; Trabado S; Maione L; Sarfati J; Le Bouc Y; Brailly-Tabard S; Fiet J; Young J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E292-6. PubMed ID: 25393641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in levels of testosterone, insulin sensitivity and metabolic profiles during GnRH therapy: Reciprocity between insulin sensitivity and pituitary responsiveness to GnRH in teenage and young male patients with congenital hypogonadotropic hypogonadism.
    Fan HQ; Wang YC; He W; Zhou HW; Yang T
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):783-791. PubMed ID: 36181235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of adipocytokine levels and vascular functions in young aged to middle aged men with idiopathic hypogonadotrophic hypogonadism.
    Tuna MM; Doğan BA; Karakılıç E; Arduç A; Işık S; Yılmaz FM; Topçuoğlu C; Berker D; Güler S
    Neuro Endocrinol Lett; 2014; 35(7):640-4. PubMed ID: 25617889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
    Sheckter CB; McLachlan RI; Tenover JS; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1221-4. PubMed ID: 3142917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
    Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
    Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.
    Dobs AS; Bachorik PS; Arver S; Meikle AW; Sanders SW; Caramelli KE; Mazer NA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1026-33. PubMed ID: 11238481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement.
    Sonmez A; Haymana C; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Dinc M; Yazici M; Taslipinar A; Barcin C; Yilmaz MI; Bolu E; Azal O
    Endocr J; 2015; 62(7):605-13. PubMed ID: 25924666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer.
    Smith JC; Bennett S; Evans LM; Kynaston HG; Parmar M; Mason MD; Cockcroft JR; Scanlon MF; Davies JS
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4261-7. PubMed ID: 11549659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour necrosis factor-alpha infusion produced insulin resistance but no change in the incretin effect in healthy volunteers.
    Nielsen ST; Lehrskov-Schmidt L; Krogh-Madsen R; Solomon TP; Lehrskov-Schmidt L; Holst JJ; Møller K
    Diabetes Metab Res Rev; 2013 Nov; 29(8):655-63. PubMed ID: 23904405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.
    Lee H; Finkelstein JS; Miller M; Comeaux SJ; Cohen RI; Leder BZ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1069-75. PubMed ID: 16352679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.
    Pitteloud N; Hardin M; Dwyer AA; Valassi E; Yialamas M; Elahi D; Hayes FJ
    J Clin Endocrinol Metab; 2005 May; 90(5):2636-41. PubMed ID: 15713702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.
    Basaria S; Muller DC; Carducci MA; Egan J; Dobs AS
    Cancer; 2006 Feb; 106(3):581-8. PubMed ID: 16388523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity.
    Mauras N; Hayes V; Welch S; Rini A; Helgeson K; Dokler M; Veldhuis JD; Urban RJ
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1886-92. PubMed ID: 9626114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: a cross-sectional analysis in middle-aged men and premenopausal women.
    Bellia A; Marinoni G; D'Adamo M; Guglielmi V; Lombardo M; Donadel G; Gentileschi P; Lauro D; Federici M; Lauro R; Sbraccia P
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4724-32. PubMed ID: 23027922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women.
    Thomas T; Burguera B; Melton LJ; Atkinson EJ; O'Fallon WM; Riggs BL; Khosla S
    Metabolism; 2000 Oct; 49(10):1278-84. PubMed ID: 11079816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.
    Costanzo PR; Suárez SM; Scaglia HE; Zylbersztein C; Litwak LE; Knoblovits P
    Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.